{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:30:08Z","timestamp":1788877808250,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05024-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:37:30Z","timestamp":1776875850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endovascular profiles linked to neutrophil activation in children and young adults with long COVID"],"prefix":"10.1038","author":[{"given":"Carly B.","family":"Steifman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Alvarez-Carcamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirandeep K.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Swank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"VanElzakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Irimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lael M.","family":"Yonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"5024_CR1","doi-asserted-by":"crossref","unstructured":"Gross, R. S. et al. Characterizing Long COVID Symptoms During Early Childhood. JAMA Pediatr. 179, 781-792 (2025).","DOI":"10.1001\/jamapediatrics.2025.1415"},{"key":"5024_CR2","first-page":"133","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023 21:3 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol. 2023 21:3"},{"key":"5024_CR3","doi-asserted-by":"crossref","unstructured":"Yonker, L. M. et al. Equity in research: a global consensus statement on the urgency of including children in long COVID clinical trials. Eur. Respir. J. 65, 2500092 (2025).","DOI":"10.1183\/13993003.00092-2025"},{"key":"5024_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chest.2021.08.010","volume":"161","author":"I Singh","year":"2022","unstructured":"Singh, I. et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest 161, 54\u201363 (2022).","journal-title":"Chest"},{"key":"5024_CR5","doi-asserted-by":"publisher","first-page":"745758","DOI":"10.3389\/fcvm.2021.745758","volume":"8","author":"S Charfeddine","year":"2021","unstructured":"Charfeddine, S. et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 8, 745758 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"5024_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03346-2","volume":"20","author":"M Haffke","year":"2022","unstructured":"Haffke, M. et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS). J. Transl. Med. 20, 1\u201311 (2022).","journal-title":"J. Transl. Med."},{"key":"5024_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"5024_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01623-4","volume":"21","author":"A Kruger","year":"2022","unstructured":"Kruger, A. et al. Proteomics of fibrin amyloid microclots in long COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 21, 1\u201323 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"5024_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius, E. et al. Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20, 1\u201318 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"5024_CR10","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1021\/acs.jproteome.5c00062","volume":"24","author":"NG Lawler","year":"2025","unstructured":"Lawler, N. G. et al. Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes. J. Proteome Res. 24, 3470\u20133483 (2025).","journal-title":"J. Proteome Res."},{"key":"5024_CR11","doi-asserted-by":"crossref","unstructured":"Thierry, A. R. et al. Circulating microclots are structurally associated with neutrophil extracellular traps and their amounts are elevated in long COVID patients. J. Med. Virol. 97, (2025).","DOI":"10.1002\/jmv.70613"},{"key":"5024_CR12","doi-asserted-by":"publisher","first-page":"35284","DOI":"10.18632\/oncotarget.6074","volume":"6","author":"J Bester","year":"2015","unstructured":"Bester, J. et al. Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget 6, 35284\u201335303 (2015).","journal-title":"Oncotarget"},{"key":"5024_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0624-5","volume":"16","author":"E Pretorius","year":"2017","unstructured":"Pretorius, E., Page, M. J., Engelbrecht, L., Ellis, G. C. & Kell, D. B. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc. Diabetol. 16, 1\u201314 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"5024_CR14","doi-asserted-by":"crossref","unstructured":"Pretorius, E. et al. Prevalence of readily detected amyloid blood clots in \u2018unclotted\u2019 Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report. Cardiovasc. Diabetol. 19, 193 (2020).","DOI":"10.1186\/s12933-020-01165-7"},{"key":"5024_CR15","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/bloodadvances.2023012473","volume":"8","author":"J Schofield","year":"2024","unstructured":"Schofield, J. et al. Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality. Blood Adv. 8, 2499 (2024).","journal-title":"Blood Adv."},{"key":"5024_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02228-6","volume":"20","author":"FJ Ryan","year":"2022","unstructured":"Ryan, F. J. et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 20, 26 (2022). 2022 20:1.","journal-title":"BMC Med."},{"key":"5024_CR17","doi-asserted-by":"crossref","unstructured":"George, P. M. et al. A persistent neutrophil-associated immune signature characterizes post\u2013COVID-19 pulmonary sequelae. Sci. Transl. Med. 14, eabo5795 (2022).","DOI":"10.1126\/scitranslmed.abo5795"},{"key":"5024_CR18","doi-asserted-by":"publisher","first-page":"1076724","DOI":"10.3389\/fimmu.2022.1076724","volume":"13","author":"LS Dean","year":"2022","unstructured":"Dean, L. S. et al. Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection. Front. Immunol. 13, 1076724 (2022).","journal-title":"Front. Immunol."},{"key":"5024_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28209","author":"E Pisareva","year":"2022","unstructured":"Pisareva, E. et al. Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.28209 (2022).","journal-title":"J. Med. Virol."},{"key":"5024_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.jtha.2023.02.033","volume":"21","author":"N Krinsky","year":"2023","unstructured":"Krinsky, N. et al. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel. J. Thromb. Haemost. 21, 2569\u20132584 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"5024_CR21","first-page":"301","volume":"98","author":"F Kov\u00e1cs","year":"2024","unstructured":"Kov\u00e1cs, F. et al. Long COVID syndrome in children: neutrophilic granulocyte dysfunction and its correlation with disease severity. Pediatr. Res. 2024 98:1 98, 301\u2013313 (2024).","journal-title":"Pediatr. Res. 2024 98:1"},{"key":"5024_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","volume":"24","author":"AD Proal","year":"2023","unstructured":"Proal, A. D. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat. Immunol. 24, 1616\u20131627 (2023).","journal-title":"Nat. Immunol."},{"key":"5024_CR23","doi-asserted-by":"crossref","unstructured":"Yonker, L. M. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. 131, e149633 (2021).","DOI":"10.1172\/JCI149633"},{"key":"5024_CR24","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2022","unstructured":"Swank, Z. et al. Persistent circulating severe acute respiratory syndrome Coronavirus 2 spike is associated with post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 76, e487 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"5024_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.cmi.2024.09.001","volume":"30","author":"Z Swank","year":"2024","unstructured":"Swank, Z. et al. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study. Clin. Microbiol. Infect. 30, 1599\u20131605 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"5024_CR26","doi-asserted-by":"crossref","unstructured":"Boribong, B. P. et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children. Cell Rep. Med. 3, 100848 (2022).","DOI":"10.1016\/j.xcrm.2022.100848"},{"key":"5024_CR27","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1021\/acs.biochem.5c00550","volume":"64","author":"H Westman","year":"2025","unstructured":"Westman, H., Hammarstr\u00f6m, P. & Nystr\u00f6m, S. SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. Biochemistry 64, 4818\u20134829 (2025).","journal-title":"Biochemistry"},{"key":"5024_CR28","unstructured":"World Health Organization. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 (2023)."},{"key":"5024_CR29","doi-asserted-by":"crossref","unstructured":"Hughes, S. E. et al. Development and validation of the symptom burden questionnaire for long COVID (SBQ-LC): Rasch analysis. BMJ 377, e070230 (2022).","DOI":"10.1136\/bmj-2022-070230"},{"key":"5024_CR30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/clinchem\/hvaa213","volume":"66","author":"AF Ogata","year":"2020","unstructured":"Ogata, A. F. et al. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin. Chem. 66, 1562\u20131572 (2020).","journal-title":"Clin. Chem."},{"key":"5024_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01579-5","volume":"21","author":"E Pretorius","year":"2022","unstructured":"Pretorius, E. et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID\/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc. Diabetol. 21, 1\u201317 (2022).","journal-title":"Cardiovasc. Diabetol."},{"key":"5024_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41586-024-07873-4","volume":"633","author":"JK Ryu","year":"2024","unstructured":"Ryu, J. K. et al. Fibrin drives thromboinflammation and neuropathology in COVID-19. Nature 633, 905\u2013913 (2024).","journal-title":"Nature"},{"key":"5024_CR33","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/jth.15830","volume":"20","author":"H Fogarty","year":"2022","unstructured":"Fogarty, H. et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thromb. Haemost. 20, 2429\u20132438 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"5024_CR34","doi-asserted-by":"crossref","unstructured":"Patel, M. A. et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol. Med. 28, 122 (2022).","DOI":"10.1186\/s10020-022-00548-8"},{"key":"5024_CR35","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41390-025-03837-0","volume":"98","author":"D Buonsenso","year":"2025","unstructured":"Buonsenso, D. et al. Distinct pro-inflammatory\/pro-angiogenetic signatures distinguish children with Long COVID from controls. Pediatr. Res. 98, 928\u2013935 (2025).","journal-title":"Pediatr. Res."},{"key":"5024_CR36","doi-asserted-by":"crossref","unstructured":"Doni, A. et al. Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus. Nat. Commun. 12, 3739 (2021).","DOI":"10.1038\/s41467-021-24021-y"},{"key":"5024_CR37","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1073\/pnas.101564798","volume":"98","author":"R Cao","year":"2001","unstructured":"Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J. & Cao, Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. USA. 98, 6390\u20136395 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5024_CR38","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.xcrm.2022.100779","volume":"3","author":"TJ LaSalle","year":"2022","unstructured":"LaSalle, T. J. et al. Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep. Med. 3, 100779 (2022).","journal-title":"Cell Rep. Med."},{"key":"5024_CR39","doi-asserted-by":"publisher","first-page":"37206","DOI":"10.1074\/jbc.M112.369942","volume":"287","author":"EPC Azevedo","year":"2012","unstructured":"Azevedo, E. P. C. et al. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase. J. Biol. Chem. 287, 37206\u201337218 (2012).","journal-title":"J. Biol. Chem."},{"key":"5024_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.4049\/jimmunol.1400281","volume":"193","author":"N Cox","year":"2014","unstructured":"Cox, N., Pilling, D. & Gomer, R. H. Distinct Fc\u03b3 Receptors Mediate the Effect of Serum Amyloid P on Neutrophil Adhesion and Fibrocyte Differentiation. J. Immunol. 193, 1701\u20131708 (2014).","journal-title":"J. Immunol."},{"key":"5024_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-40012-7","volume":"14","author":"MC Woodruff","year":"2023","unstructured":"Woodruff, M. C. et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat. Comm. 14, 1\u201313 (2023). 2023 14:1.","journal-title":"Nat. Comm."},{"key":"5024_CR42","doi-asserted-by":"publisher","unstructured":"Laubscher, G. J. et al. Treatment of Long COVID symptoms with triple anticoagulant therapy. https:\/\/doi.org\/10.21203\/RS.3.RS-2697680\/V1 (2023).","DOI":"10.21203\/RS.3.RS-2697680\/V1"},{"key":"5024_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","volume":"15","author":"JW Yau","year":"2015","unstructured":"Yau, J. W., Teoh, H. & Verma, S. Endothelial cell control of thrombosis. BMC Cardiovasc. Disord. 15, 130 (2015).","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05024-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:37:39Z","timestamp":1776875859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05024-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":43,"alternative-id":["5024"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05024-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AF is currently the Chief Science and Medical Officer at Mead Johnson Nutrition. Dr. Walt has a financial interest in Quanterix Corporation, a company that develops an ultrasensitive digital immunoassay platform. He is an inventor of the Simoa technology, a founder of the company, and also serves on its Board of Directors. Dr. Grabowski is a member of the Scientific Advisory Board for Sanofi-Genzyme. Conflicts of interest were reviewed and are managed by Massachusetts General Brigham in accordance with its conflict of interest policies. The remaining authors have disclosed that they do not have any potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants signed a consent, plus an assent if 7 through 17 years of age, prior to study participation. All procedures were completed in accordance with IRB-approved protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}